InvestorsObserver is giving Portage Biotech Inc (PRTG) an Analyst Rating Rank of 5, meaning PRTG is ranked higher by analysts than 5% of stocks. The average price target for PRTG is $7 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating PRTG a Hold today. Find out what this means to you and get the rest of the rankings on PRTG!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Portage Biotech Inc Stock Today?
Portage Biotech Inc (PRTG) stock has risen 3.64% while the S&P 500 is lower by -0.35% as of 11:03 AM on Tuesday, Jan 16. PRTG is up $0.04 from the previous closing price of $1.10 on volume of 5,840 shares. Over the past year the S&P 500 has risen 19.44% while PRTG is lower by -78.29%. PRTG lost -$6.52 per share the over the last 12 months.
Click Here to get the full Stock Report for Portage Biotech Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
